(EL) EssilorLuxottica S. A. - Ratings and Ratios
Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0000121667
EL: Lenses, Frames, Sunglasses, Equipment, Instruments, Eyewear
EssilorLuxottica stands as a titan in the global eyewear industry, forged through the merger of two legends: Essilor, the pioneer in lens innovation, and Luxottica, the powerhouse behind iconic eyewear brands. This union created an unparalleled entity, dominationg every link in the value chain from lens manufacturing to brand distribution.
The companys arsenal boasts an impressive array of brands, blending luxury and functionality. On one end, you have the likes of Ray-Ban and Oakley, titans in the premium eyewear space. On the other, Essilors Varilux and Crizal lenses showcase cutting-edge technology, addressing diverse vision needs. This strategic diversification ensures a foothold in every market segment, catering to both the fashion-forward and those seeking functional solutions.
EssilorLuxotticas operational prowess is a masterclass in scale and efficiency. They arm opticians and labs with state-of-the-art equipment, streamlining production. Their global reach is unmatched, serving everyone from independent opticians to massive retailers, plus a robust direct-to-consumer play. This dual approach ensures they capture every sales channel, leaving no stone unturned in their market dominance.
Looking at the numbers, their market cap exceeds €121 billion, a testament to their stability and scale. The current P/E ratio of 52.72 reflects high valuations, likely due to growth expectations, while the forward P/E of 34.13 hints at anticipated expansion. The P/S ratio of 4.70 underscores their substantial revenue generation relative to their size.
For investors, EssilorLuxottica presents a compelling case. Their leadership in innovation and extensive distribution networks position them to capitalize on the growing eyewear demand. With a strong balance sheet and global presence, they are a beacon of stability and growth potential in their sector.
Additional Sources for EL Stock
EL Stock Overview
Market Cap in USD | 140,600m |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
GiC Sub-Industry | Health Care Equipment |
IPO / Inception |
EL Stock Ratings
Growth 5y | 86.1% |
Fundamental | 47.4% |
Dividend | 61.8% |
Rel. Strength Industry | 53.1 |
Analysts | - |
Fair Price Momentum | 315.81 EUR |
Fair Price DCF | 179.83 EUR |
EL Dividends
Dividend Yield 12m | 1.55% |
Yield on Cost 5y | 3.17% |
Annual Growth 5y | 27.99% |
Payout Consistency | 98.0% |
EL Growth Ratios
Growth Correlation 3m | 91.6% |
Growth Correlation 12m | 89.6% |
Growth Correlation 5y | 92% |
CAGR 5y | 18.05% |
CAGR/Max DD 5y | 0.60 |
Sharpe Ratio 12m | 2.02 |
Alpha | 39.93 |
Beta | 0.46 |
Volatility | 14.92% |
Current Volume | 802.3k |
Average Volume 20d | 607k |
As of February 22, 2025, the stock is trading at EUR 290.90 with a total of 802,344 shares traded.
Over the past week, the price has changed by -1.22%, over one month by +16.36%, over three months by +25.17% and over the past year by +56.62%.
Partly, yes. Based on ValueRay Fundamental Analyses, EssilorLuxottica S. A. (PA:EL) is currently (February 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 47.36 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EL as of February 2025 is 315.81. This means that EL is currently overvalued and has a potential downside of 8.56%.
EssilorLuxottica S. A. has no consensus analysts rating.
According to ValueRays Forecast Model, EL EssilorLuxottica S. A. will be worth about 363.7 in February 2026. The stock is currently trading at 290.90. This means that the stock has a potential upside of +25.03%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 265.6 | -8.7% |
Analysts Target Price | - | - |
ValueRay Target Price | 363.7 | 25% |